Processa Pharmaceuticals, Inc. License Agreements
10 Contracts & Agreements
- License Agreement dated June 16, 2021 (Filed With SEC on June 17, 2021)
- Addendum No. 1 to the Aposense Ltd. License Agreement (Filed With SEC on March 25, 2021)
- License Agreement with Elion Oncology, Inc (Filed With SEC on September 17, 2020)
- License Agreement with Yuhan Corporation (Filed With SEC on September 17, 2020)
- License Agreement with Aposense, Ltd. dated May 24, 2020 (Filed With SEC on September 17, 2020)
- License Agreement with Akashi Therapeutics, Inc. dated August 29, 2019 (Filed With SEC on September 17, 2020)
- License Option Agreement with CoNCERT (Filed With SEC on September 17, 2020)
- License Agreement by and between Processa Pharmaceuticals and Elion Oncology dated August 23, 2020 (Filed With SEC on August 27, 2020)
- License Agreement by and between Processa Pharmaceuticals, Inc. and Yuhan Corporation, dated August 19, 2020 (Filed With SEC on August 20, 2020)
- License Option Agreement with CoNCERT (Filed With SEC on April 16, 2018)
